![Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines | Science Advances Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines | Science Advances](https://www.science.org/cms/10.1126/sciadv.aaz6225/asset/1c83cffe-a96c-4aec-bbe7-19343a91886e/assets/graphic/aaz6225-f1.jpeg)
Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines | Science Advances
![Reinfection Rates Low after Successful HCV Treatment in People Who Inject Drugs | Today's Clinical Lab Reinfection Rates Low after Successful HCV Treatment in People Who Inject Drugs | Today's Clinical Lab](https://cdn.clinicallabmanager.com/assets/articleNo/26657/aImg/49968/reinfection-rates-low-after-successful-hcv-treatment-in-people-who-inject-drugs-l.jpg)
Reinfection Rates Low after Successful HCV Treatment in People Who Inject Drugs | Today's Clinical Lab
![World Hepatitis Day: Unitaid reaffirms its commitment to make hepatitis C elimination a reality by putting affected people at the heart of the response - Unitaid World Hepatitis Day: Unitaid reaffirms its commitment to make hepatitis C elimination a reality by putting affected people at the heart of the response - Unitaid](https://unitaid.org/assets/hep-C-for-web.jpg)
World Hepatitis Day: Unitaid reaffirms its commitment to make hepatitis C elimination a reality by putting affected people at the heart of the response - Unitaid
![Hepatitis C Blood Test Tube Samples in Laboratory, Hepatitis C Vaccine Stock Image - Image of background, cellulitis: 208812389 Hepatitis C Blood Test Tube Samples in Laboratory, Hepatitis C Vaccine Stock Image - Image of background, cellulitis: 208812389](https://thumbs.dreamstime.com/z/hepatitis-c-blood-test-tube-samples-laboratory-hepatitis-c-vaccine-hepatitis-c-blood-test-tube-samples-laboratory-hepatitis-208812389.jpg)